Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Summit Therapeu ADR
(NQ:
SMMT
)
17.83
-0.04 (-0.22%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Summit Therapeu ADR
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
June 17, 2024
These high-flying stocks could have more room to run if analysts are right.
Via
The Motley Fool
Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million
June 08, 2024
Structure Therapeutics announced positive clinical results for its obesity drug, and then raised $476 million via an offering of its ADSs. Meanwhile, Alphamab Oncology announced a deal with ArriVent...
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
June 07, 2024
Via
Benzinga
Five Below Posts Weak Q1 Results, Joins Sprinklr, Dorian LPG And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
June 06, 2024
Via
Benzinga
Why Summit Therapeutics Stock Is Trading 8% Higher Monday
June 03, 2024
Based on data from a Phase III HARMONi-A clinical trial, sponsored by Akeso, that showed promising results for treating certain cancers, China granted Summit the marketing authorization.
Via
Benzinga
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
June 03, 2024
Via
Benzinga
Summit Raises $200 Million; Also Expands License Territories for Ivonescimab
June 03, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Day Trading During A Slow Holiday Week
June 01, 2024
We made it to the end of a holiday-shortened week. It was a slow week of day trading, but I’m happy with how it finished. Let’s break it down in today’s recap.
Via
Talk Markets
Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership
June 01, 2024
Suzhou MediLink partnered with Germany’s BioNTech to use MediLink’s TMALIN antibody-drug conjugate platform. MediLink will receive an upfront payment of $25 million and up to $1.8 billion in...
Via
Talk Markets
Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA
June 01, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy
May 31, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 31, 2024
Via
Benzinga
Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus Merck's Multi-Billion Keytruda In China Study
May 31, 2024
Summit Therapeutics shares dropped 27.3% to $7.94 in premarket trading Friday after a 272.1% surge on Thursday. The company announced Phase 3 HARMONi-2 trial results, where ivonescimab significantly...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 31, 2024
Via
Benzinga
Why Zscaler Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
May 31, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 31, 2024
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers on Friday morning!
Via
InvestorPlace
Marvell Technology Posts Weak Q1 Results, Joins MongoDB, Dell Technologies And Other Big Stocks Moving Lower In Friday's Pre-Market Session
May 31, 2024
Via
Benzinga
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 30, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC in China
May 30, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 28, 2024
Via
Benzinga
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 28, 2024
Via
Benzinga
Why Summit Therapeutics Stock Is Sinking Today
May 28, 2024
Investors continue to react negatively to recent late-stage results for Summit's experimental cancer therapy.
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 27, 2024
Via
Benzinga
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 24, 2024
Via
Benzinga
Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
May 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 24, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 24, 2024
We're diving into the biggest pre-market stock movers that traders need to know about on Friday morning with all of the latest news!
Via
InvestorPlace
Intuit, Workday And Other Big Stocks Moving Lower In Friday's Pre-Market Session
May 24, 2024
Via
Benzinga
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
May 07, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.